These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36542644)

  • 21. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
    Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
    Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 24. Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients: evidence from a Swiss population-based study.
    Feller A; Schmidlin K; Bordoni A; Bouchardy C; Bulliard JL; Camey B; Konzelmann I; Maspoli M; Wanner M; Zwahlen M; Clough-Gorr KM;
    Cancer Med; 2018 Apr; 7(4):1498-1510. PubMed ID: 29479854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time Trends in Colorectal Cancer Incidence Rates by Income and Age at Diagnosis in Canada From 1992 to 2016.
    Decker KM; Lambert P; Bravo J; Demers A; Singh H
    JAMA Netw Open; 2021 Jul; 4(7):e2117556. PubMed ID: 34279645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?
    Flander L; Dekker E; Andersen B; Larsen MB; Steele RJ; Malila N; Sarkeala T; van der Vlugt M; de Klerk C; Knottnerus B; Bertels L; Woudstra A; Spaander MCW; Fransen M; Heinavaara S; Dillon M; Ait Ouakrim D; Jenkins M
    Cancer Control; 2022; 29():10732748221121383. PubMed ID: 35969473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.
    Beckmann KR; Bennett A; Young GP; Cole SR; Joshi R; Adams J; Singhal N; Karapetis C; Wattchow D; Roder D
    BMC Health Serv Res; 2016 Jan; 16():24. PubMed ID: 26792195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs.
    Zgraggen A; Stoffel ST; Barbier MC; Marbet UA
    Z Gastroenterol; 2022 May; 60(5):761-778. PubMed ID: 35545112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia.
    Ward PR; Javanparast S; Matt MA; Martini A; Tsourtos G; Cole S; Gill T; Aylward P; Baratiny G; Jiwa M; Misan G; Wilson C; Young G
    Aust N Z J Public Health; 2011 Feb; 35(1):61-5. PubMed ID: 21299702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of family history-based colorectal cancer screening in Australia.
    Ouakrim DA; Boussioutas A; Lockett T; Hopper JL; Jenkins MA
    BMC Cancer; 2014 Apr; 14():261. PubMed ID: 24735237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Adenoma Detection Rate and Adenoma Characteristics With Colorectal Cancer Mortality After Screening Colonoscopy.
    Waldmann E; Kammerlander AA; Gessl I; Penz D; Majcher B; Hinterberger A; Bretthauer M; Trauner MH; Ferlitsch M
    Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1890-1898. PubMed ID: 33878471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
    Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of screening strategies for colorectal cancer.
    Barzi A; Lenz HJ; Quinn DI; Sadeghi S
    Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening for average-risk North Americans: an economic evaluation.
    Heitman SJ; Hilsden RJ; Au F; Dowden S; Manns BJ
    PLoS Med; 2010 Nov; 7(11):e1000370. PubMed ID: 21124887
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.